Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

4.630 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Taysha Gene Therapies Touts Encouraging Preclinical Data From Rett Syndrome Candidate ↗

May 19, 2023

Taysha Gene Therapies Inc (NASDAQ: TSHA) presented preclinical data from neonatal mouse models on TSHA-102 for Rett syndrome, including new data in wild-type mice, at the American Society of Gene and...

Via Benzinga

FDA's Approval For Sarepta's Duchenne Gene Therapy, A Boost for Taysha Gene's Rare Neuropathy Treatment: Analyst Weighs ↗

May 15, 2023

On Friday, the FDA's adcomm voted 8 to 6 in support of accelerated approval of Sarepta Therapeutics Inc's SRPT SRP-9001 (delandistrogene moxeparvovec) for ambulatory patients with

Via Benzinga

Analyst Ratings for Taysha Gene Therapies ↗

May 12, 2023

Via Benzinga

Recap: Taysha Gene Therapies Q1 Earnings ↗

May 11, 2023

Via Benzinga

Earnings Preview: Taysha Gene Therapies ↗

May 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 29, 2023

On Wednesday, 81 companies hit new 52-week lows.

Via Benzinga

12 Analysts Have This to Say About Taysha Gene Therapies ↗

March 29, 2023

Via Benzinga

Taysha Gene Therapies's Earnings: A Preview ↗

March 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 15, 2023

On Wednesday, 479 stocks made new 52-week lows.

Via Benzinga

Analyst Ratings for Taysha Gene Therapies ↗

January 27, 2023

Via Benzinga

Expert Ratings for Taysha Gene Therapies ↗

January 04, 2023

Via Benzinga

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 24, 2023

On Friday, 135 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 24, 2023

On Friday, 469 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

March 16, 2023

Thursday's session saw 337 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 15, 2023

On Wednesday, 35 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 10, 2023

During Friday, 48 stocks hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023 ↗

February 02, 2023

Via Benzinga

US Stocks Turn Higher After Fed Raises Key Overnight Interest Rate; Nasdaq Up 1.5% ↗

February 01, 2023

U.S. stocks turned higher toward the end of trading, following the release of interest rate decision. The Dow traded up 0.05% to 34,104.56 while the NASDAQ rose 1.58% to 11,767.44. The S&P 500 also...

Via Benzinga

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 01, 2023

Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 01, 2023

Via Benzinga

Dow Dips 300 Points; Snap Shares Plunge ↗

February 01, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023 ↗

February 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 01, 2023

Via Benzinga

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket ↗

February 01, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 01, 2023

It's time for another look at the biggest pre-market stock movers worth checking out as we start off trading early on Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 30, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

JMP Securities Maintains Market Outperform Rating for Taysha Gene Therapies: Here's What You Need To Know ↗

January 19, 2023

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.